Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.375 EUR
309.22 M EUR
1.78 B EUR
221.23 M
About Qiagen N.V.
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015001WM6
FIGI
BBG000H50QW6
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of QIA is 39.915 EUR — it has increased by 0.50% in the past 24 hours. Watch QIAGEN NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange QIAGEN NV stocks are traded under the ticker QIA.
QIA stock has fallen by −4.03% compared to the previous week, the month change is a −1.63% fall, over the last year QIAGEN NV has showed a 4.98% increase.
We've gathered analysts' opinions on QIAGEN NV future price: according to them, QIA price has a max estimate of 56.64 EUR and a min estimate of 40.12 EUR. Watch QIA chart and read a more detailed QIAGEN NV stock forecast: see what analysts think of QIAGEN NV and suggest that you do with its stocks.
QIA stock is 3.42% volatile and has beta coefficient of 0.51. Track QIAGEN NV stock price on the chart and check out the list of the most volatile stocks — is QIAGEN NV there?
Today QIAGEN NV has the market capitalization of 8.59 B, it has decreased by −0.13% over the last week.
Yes, you can track QIAGEN NV financials in yearly and quarterly reports right on TradingView.
QIAGEN NV is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
QIA earnings for the last quarter are 0.51 EUR per share, whereas the estimation was 0.49 EUR resulting in a 4.91% surprise. The estimated earnings for the next quarter are 0.57 EUR per share. See more details about QIAGEN NV earnings.
QIAGEN NV revenue for the last quarter amounts to 450.75 M EUR, despite the estimated figure of 441.16 M EUR. In the next quarter, revenue is expected to reach 494.02 M EUR.
QIA net income for the last quarter is 88.07 M EUR, while the quarter before that showed −171.28 M EUR of net income which accounts for 151.42% change. Track more QIAGEN NV financial stats to get the full picture.
QIAGEN NV dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 5.97 K employees. See our rating of the largest employees — is QIAGEN NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QIAGEN NV EBITDA is 611.86 M EUR, and current EBITDA margin is 33.10%. See more stats in QIAGEN NV financial statements.
Like other stocks, QIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QIAGEN NV technincal analysis shows the neutral today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QIAGEN NV stock shows the neutral signal. See more of QIAGEN NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.